Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial to evaluate the efficacy of fluvastatin on certain markers

Trial Profile

Trial to evaluate the efficacy of fluvastatin on certain markers

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Dyslipidaemias
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 07 Nov 2011 Actual end date (1 Jun 2007) added as reported by ClinicalTrials.gov.
    • 21 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top